A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene - PubMed (original) (raw)
. 1999 May;104(5):418-24.
doi: 10.1007/s004390050978.
Affiliations
- PMID: 10394935
- DOI: 10.1007/s004390050978
A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene
C E Bruder et al. Hum Genet. 1999 May.
Abstract
Schwannomas are tumors arising mainly at cranial and spinal nerves. Bilateral vestibular schwannoma is the hallmark of neurofibromatosis type2 (NF2). The NF2 gene has been cloned and comprehensive analysis of its mutations in schwannomas shows that up to 60% of tumors carry inactivating mutations. Thus, the genetic mechanism behind the development of more than 40% of schwannomas without NF2 mutations is unknown. We have therefore studied tumor tissue from 50 human schwannomas by allelotyping and have found chromosome 22 deletions in over 80% of the cases. We detected 14 cases (27%) that revealed partial deletions of one copy of chromosome 22, i.e., terminal and/or interstitial deletions. We sequenced the NF2 gene in seven of these tumors and detected only one case with mutations. The deletion mapping of chromosome 22 in tumors with partial deletions indicates that several regions, in addition to the NF2 locus, harbor genes involved in schwannoma tumorigenesis. Our findings suggest that heterogeneity in the mechanisms leading to the development of schwannomas probably exists. These findings are in agreement with the recent analysis of schwannomas from familial and sporadic cases of schwannomatosis and point to a possible role of an additional gene, which, in cooperation with the NF2 tumor suppressor, causes schwannomas.
Similar articles
- The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA. Twist EC, et al. Hum Mol Genet. 1994 Jan;3(1):147-51. doi: 10.1093/hmg/3.1.147. Hum Mol Genet. 1994. PMID: 8162016 - Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP. Ng HK, et al. Neurosurgery. 1995 Oct;37(4):764-73. doi: 10.1227/00006123-199510000-00022. Neurosurgery. 1995. PMID: 8559307 - Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE, Ichimura K, Blennow E, Ikeuchi T, Yamaguchi T, Yuasa Y, Collins VP, Dumanski JP. Bruder CE, et al. Genes Chromosomes Cancer. 1999 Jun;25(2):184-90. Genes Chromosomes Cancer. 1999. PMID: 10338003 - [Neurofibromatosis type 2 (NF2)].
Araki N, Takeshima H, Saya H. Araki N, et al. Gan To Kagaku Ryoho. 1997 Sep;24(11):1427-31. Gan To Kagaku Ryoho. 1997. PMID: 9309136 Review. Japanese. - [Molecular biological analysis of neurofibromatosis type 2 gene].
Ichimura K, Yuasa Y. Ichimura K, et al. Nihon Rinsho. 1993 Sep;51(9):2462-6. Nihon Rinsho. 1993. PMID: 8411729 Review. Japanese.
Cited by
- Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
Bian LG, Tirakotai W, Sun QF, Zhao WG, Shen JK, Luo QZ. Bian LG, et al. J Neurooncol. 2005 Jul;73(3):253-60. doi: 10.1007/s11060-004-5176-3. J Neurooncol. 2005. PMID: 15980976 - The molecular biology of vestibular schwannomas and its association with hearing loss: a review.
Celis-Aguilar E, Lassaletta L, Torres-Martín M, Rodrigues FY, Nistal M, Castresana JS, Gavilan J, Rey JA. Celis-Aguilar E, et al. Genet Res Int. 2012;2012:856157. doi: 10.1155/2012/856157. Epub 2012 Feb 20. Genet Res Int. 2012. PMID: 22567403 Free PMC article. - High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.
Díaz de Ståhl T, Hansson CM, de Bustos C, Mantripragada KK, Piotrowski A, Benetkiewicz M, Jarbo C, Wiklund L, Mathiesen T, Nyberg G, Collins VP, Evans DG, Ichimura K, Dumanski JP. Díaz de Ståhl T, et al. Hum Genet. 2005 Oct;118(1):35-44. doi: 10.1007/s00439-005-0002-3. Epub 2005 Oct 28. Hum Genet. 2005. PMID: 16078050 - Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.
Doddrell RD, Dun XP, Shivane A, Feltri ML, Wrabetz L, Wegner M, Sock E, Hanemann CO, Parkinson DB. Doddrell RD, et al. Brain. 2013 Feb;136(Pt 2):549-63. doi: 10.1093/brain/aws353. Brain. 2013. PMID: 23413263 Free PMC article. - The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases.
Lasota J, Fetsch JF, Wozniak A, Wasag B, Sciot R, Miettinen M. Lasota J, et al. Am J Pathol. 2001 Apr;158(4):1223-9. doi: 10.1016/S0002-9440(10)64072-2. Am J Pathol. 2001. PMID: 11290539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous